Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies.
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies. Oncologist. 2018 02; 23(2):159-170.
View in:
PubMed
subject areas
Antimetabolites, Antineoplastic
Azacitidine
Humans
Myelodysplastic Syndromes
Prognosis
Prospective Studies
authors with profiles
David L. Grinblatt